Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta
Trial details
- Registry ID
- NCT07108153
- Drugs studied
- SION-719
TrialRedline tracks 1 clinical trial sponsored by Sionna Therapeutics Inc.: 1 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to TrikaftaNCT07108153 | SION-719 | Completed | 2026-06-25Actual |
Names as written in the registry records.
NCT07108153 · Sionna Therapeutics Inc.
Before: Estimated. After: Actual.
Before: 16 participants (planned). After: 15 participants (actual).
Before: Estimated. After: Actual.
Before: Jul 2026. After: 25 Jun 2026.
Before: Active not recruiting. After: Completed.
NCT07108153 · Sionna Therapeutics Inc.
Before: Recruiting. After: Active not recruiting.